focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNinety One Regulatory News (N91)

Share Price Information for Ninety One (N91)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 175.40
Bid: 175.20
Ask: 175.60
Change: 0.70 (0.40%)
Spread: 0.40 (0.228%)
Open: 172.40
High: 176.00
Low: 172.40
Prev. Close: 174.70
N91 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

3 Nov 2023 07:05

RNS Number : 2433S
Ninety One PLC
03 November 2023
 

Ninety One plc ? ? Ninety One Limited

Incorporated in England and Wales ? Incorporated in the Republic of South Africa

Registration number 12245293 ? Registration number 2019/526481/06

Date of registration: 4 October 2019 ? Date of registration: 18 October 2019

LSE share code: N91 ? JSE share code: NY1

JSE share code: N91 ? ? ISIN: ZAE000282356

ISIN: GB00BJHPLV88

 

As part of the dual-listed company structure, the boards of Ninety One plc and Ninety One Limited (together the 'Board') notify both the London Stock Exchange and the JSE Limited ('JSE') of matters which are required to be disclosed under the FCA Disclosure Guidance and Transparency Rules and Listing Rules of the United Kingdom Listing Authority (the 'UKLA') and/or the JSE Listings Requirements (the 'Listing Requirements').

 

Ninety One Limited Ordinary Share Buyback

Ninety One Limited (the 'Company') advises that, at the close of business on 01 November 2023, it has cumulatively repurchased 8,900,922 of the Company's ordinary shares ('Ordinary Shares') representing 3.007% of the issued Ordinary Share capital as at the date of the general authority granted by shareholders at the Company's annual general meeting held on 26 July 2023 ('General Authority').

The Ordinary Shares were repurchased for an aggregate value of R345,632,678.38. Details of the repurchase are set out in the table hereunder:

 

Repurchase period

Number and percentage of shares repurchased

Highest repurchase price per share (R)

Lowest repurchase price per share (R)

Aggregate value (R)

Number and percentage of shares outstanding in relation to the total shares under the General Authority

27 July -

1 November 2023

8,900,922

3.007%

R40.00

R35.89

R345,632,678.38

20,695,450

6.993%

 

An application will be made to the JSE to de-list 307,360 Ordinary Shares, at which point they will be immediately cancelled. 8,593,562 Ordinary Shares have already been cancelled. The Ordinary Shares remaining in issue following the cancellation of the aforementioned shares amounts to 287,062,798. The Company does not hold any treasury shares.

 

The impact of the repurchase of the Ordinary Shares on the financial information of the Company is immaterial. The Ordinary Shares were repurchased from excess cash resources of the Company; going forward, no Ordinary Share dividends will be payable on the repurchased Ordinary Shares and interest earned on the cash utilised for the repurchases will be foregone. 

 

On 27 July 2023, in accordance with paragraph 5.72(h) of the JSE Listings Requirements, the Company entered into a mandate (the 'Mandate') with an independent agent to undertake its repurchase programme. Under the Mandate, the repurchase programme continued during the Company's closed period from 1 October to 15 November 2023. The repurchases were made in terms of the current General Authority effected through an order book operated by the JSE and executed without any prior understanding or arrangement between the Company and the counterparties. Accordingly, the Company has complied with paragraph 5.72(a) of the Listings Requirements.

 

 

Statement by the Board

The Board has considered the effect of the repurchases and is of the opinion that, for a period of 12 months following the repurchases, the:

? Company and its subsidiaries (the 'Group') will be able, in the ordinary course of business, to pay its debts;

? consolidated assets of the Company and the Group will be in excess of the consolidated liabilities;

? share capital and reserves of the Company and the Group will be adequate for ordinary business purposes; and

? working capital of the Company and the Group will be adequate for ordinary business purposes.

 

 

For enquiries please contact:

 

Investor relations

Alvar Fernandez alvar.fernandez@ninetyone.com +44 (0) 20 3938 2305

Jakub Vojtek jakub.vojtek@ninetyone.com +44 (0) 20 3938 2413

 

 

Date of release: ?03 November 2023

JSE Sponsor: J.P. Morgan Equities South Africa (Pty) Ltd

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAKFAEEEDFFA
Date   Source Headline
13th Mar 20231:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20231:00 pmRNSDirector/PDMR Shareholding
17th Feb 20232:30 pmRNSAudit & Risk Committee Retirement and Appointment
16th Feb 20231:00 pmRNSDirector/PDMR Shareholding
13th Feb 20231:00 pmRNSDirector/PDMR Shareholding
9th Feb 20231:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20231:00 pmRNSDirector/PDMR Shareholding
30th Jan 20231:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20231:00 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSQ3 2023 AUM update
17th Jan 20237:00 amRNS2022 AGM - Voting Results Update
22nd Dec 202211:00 amRNSDirector/PDMR Shareholding
21st Dec 202211:00 amRNSDirector/PDMR Shareholding
19th Dec 20221:00 pmRNSDirector/PDMR Shareholding
15th Dec 20221:00 pmRNSDirector/PDMR Shareholding
13th Dec 20221:00 pmRNSDirector/PDMR Shareholding
8th Dec 20221:00 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector Declaration
5th Dec 20221:00 pmRNSDirector/PDMR Shareholding
28th Nov 202212:00 pmRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSHalf-year Report and Dividend Declaration
24th Oct 20224:00 pmRNSHolding(s) in Company
18th Oct 20227:00 amRNSQ2 2023 AUM update
3rd Oct 20222:00 pmRNSDirector/PDMR Shareholding
27th Sep 20221:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20221:00 pmRNSDirector/PDMR Shareholding
20th Sep 20223:00 pmRNSDirector/PDMR Shareholding
20th Sep 20223:00 pmRNSHolding(s) in Company
16th Sep 20221:00 pmRNSDirector/PDMR Shareholding
15th Sep 20221:00 pmRNSDirector/PDMR Shareholding
12th Sep 20221:00 pmRNSDirector/PDMR Shareholding
8th Sep 20221:00 pmRNSDirector/PDMR Shareholding
5th Sep 20221:00 pmRNSDirector/PDMR Shareholding
1st Sep 20221:00 pmRNSDirector/PDMR Shareholding
30th Aug 20221:00 pmRNSDirector/PDMR Shareholding
26th Aug 20221:00 pmRNSDirector/PDMR Shareholding
25th Aug 20221:00 pmRNSDirector/PDMR Shareholding
23rd Aug 20221:00 pmRNSDirector/PDMR Shareholding
23rd Aug 20229:00 amRNSHolding(s) in Company
19th Aug 20221:00 pmRNSDirector/PDMR Shareholding
17th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 20221:00 pmRNSDirector/PDMR Shareholding
10th Aug 20221:00 pmRNSDirector/PDMR Shareholding
5th Aug 20221:00 pmRNSDirector/PDMR Shareholding
3rd Aug 20221:00 pmRNSDirector/PDMR Shareholding
29th Jul 20221:00 pmRNSDirector/PDMR Shareholding
27th Jul 20224:00 pmRNSB-BBEE Act: Annual Compliance Report
27th Jul 20221:00 pmRNSDirector/PDMR Shareholding
27th Jul 20227:00 amRNSResult of AGM
25th Jul 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.